Clinical Trial Update: Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating erythropoietin to treat anemia in chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Anemia, Chronic Obstructive Pulmonary Disease | Phase 3 | Status: WITHDRAWN